Vitreous haemorrhage in elderly patients: Management and prevention

Drugs and Aging

Volumn 20, Issue 9, 2003, Pages 655-661

  Manuchehri, Kaykhosrov ^a   Kirkby, Graham R ^a  

^a CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DIPYRIDAMOLE; OCTREOTIDE; SOMATOSTATIN DERIVATIVE;

B SCAN; ECHOGRAPHY; EYE FUNDUS; HEART INFARCTION; HUMAN; LASER SURGERY; PRIORITY JOURNAL; RETINA BLOOD VESSEL; RETINA DETACHMENT; RETINA EXAMINATION; RETINA TEAR; RETINA VEIN OCCLUSION; REVIEW; RISK MANAGEMENT; STROKE; VITRECTOMY; VITREOUS HEMORRHAGE;

AGED; DIABETIC RETINOPATHY; DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; HUMANS; PATIENT CARE MANAGEMENT; RETINAL DETACHMENT; RETINAL PERFORATIONS; VITRECTOMY; VITREOUS HEMORRHAGE;

EID: 0041669592     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002512-200320090-00003     Document Type: Review

References (44)

1. Spraul CW, Grossniklaus HE. Vitreous hemorrhage. Surv Ophthalmol 1997; 42 (1): 3-39
2. Lindgren G, Lindblom B. Causes of vitreous hemorrhage [review]. Curr Opin Ophthalmol 1996; 7 (3): 13-9
3. Lindgren G, Sjodell L, Lindblom B. A prospective study of dense spontaneous vitreous hemorrhage. Am J Ophthalmol 1995; 119 (4): 458-65
4. Byer NE. Natural history of posterior vitreous detachment with early management as the premier line of defense against retinal detachment. Ophthalmology 1994; 101 (9): 1503-13
5. Wilkinson CP, Rice TA. Michel's retinal detachment. 2nd ed. St Louis: CV Mosby, 1997: 31
6. Sharma S, Walker R, Brown GC, et al. The importance of qualitative vitreous examination in patients with acute posterior vitreous detachment. Arch Ophthalmol 1999; 117 (3): 343-6
7. Richardson PS, Benson MT, Kirkby GR. The posterior vitreous detachment clinic: do new retinal breaks develop in the six weeks following an isolated symptomatic posterior vitreous detachment? Eye 1999; 13 (Pt 2): 237-40
8. Sarrafizadeh R, Hassan TS, Ruby AJ, et al. Incidence of retinal detachment and visual outcome in eyes presenting with posterior vitreous separation and dense fundus-obscuring vitreous hemorrhage. Ophthalmology 2001; 108 (12): 2273-8
9. Tolentino FL, Lee P-F, Schepens CL. Biomicroscopic study of vitreous cavity in diabetic retinopathy. Arch Ophthalmol 1967; 75: 23-30
10. Dana MR, Werner MS, Viana MA, et al. Spontaneous and traumatic vitreous haemorrhage. Ophthalmology 1993; 100: 1377-83
11. Hayreh SS, Rojas P, Podhajsky P, et al. Ocular neovasularization with retinal vascular occlusion: III. incidence of ocular neovascuarization with retinal vein occlusion. Ophthalmology 1983; 90: 488-509
12. Dodson PM, Kritzinger EE, Clough CG. Diabetes mellitus and retinal vein occlusion in patients of Asian, West Indian and White European origin. Eye 1992; 6: 66-8
13. Rabb MF, Gagliano DA, Teske MP. Retinal arterial microaneurysms. Surv Ophthalmol 1988; 33: 73-96
14. Ohno-Matsui K, Hayano M, Futagami S, et al. Spontaneous involution of a large retinal arterial macroaneurysm. Acta Ophthalmol Scand 2000; 78 (1): 114-7
15. Cunliffe IA, Rennie IG. Choroidal melanoma presenting as vitreous haemorrhage. Eye 1993; 7: 711-3
16. Gunduz K, Shields CL, Shields JA, et al. Presumed choroidal granuloma with vitreous hemorrhage resembling choroidal melanoma. Ophthalmic Surg Lasers 1998; 29 (5): 422-5
17. Ogawa T, Kitaoka T, Dake Y, et al. Terson syndrome: a case report suggesting the mechanism of vitreous hemorrhage. Ophthalmology 2001; 108 (9): 1654-6
18. McRae M, Teasell RW, Canny C. Bilateral retinal detachments associated with Tersons syndrome. Retina 1994; 14 (5): 467-9
19. Naseri A, Blumenkranz MS, Horton JC. Terson's syndrome following epidural saline injection [letter]. Neurology 2001; 57 (2): 364
20. Gnanaraj L, Tyagi AK, Cottrell DG, et al. Referral delay and ocular surgical outcome in Terson syndrome. Retina 2000; 20 (4): 374-7
21. Purdie AT, Olson JA. A case of pseudo-Terson's syndrome. Eye 1999; 13: 690-1
22. Chen S, Cahill M, Barry P. Cluster of four cases of inadvertent injury to the globe secondary to peribulbar anaesthesia. Br J Ophthalmol 1998; 82 (7): 850-1
23. Wearne MJ, Flaxel CJ, Gray P, et al. Vitreoretinal surgery after inadvertent globe penetration during local ocular anesthesia. Ophthalmology 1998; 105 (2): 371-6
24. Labelle PF, Lapointe A, Boucher MC. Vitreous hemorrhage following retrobulbar anaesthesia. Can J Ophthalmol 1996; 31 (1): 21-4
25. Gillow JT, Aggarwal RK, Kirkby GR. Ocular perforation during peribulbar anaesthesia. Eye 1996; 10 (Pt 5): 533-6
26. Kersey JP, Sleep T, Hodgkins PR. Ocular perforation associated with local anaesthetic for dacryocystorhinostomy. Eye 2001; 15 (Pt 5): 671-2
27. Dinakaran S, Kayarkar VV. Intraoperative ocular damage caused by a cannula. J Cataract Refract Surg 1999 May; 25 (5): 720-1
28. Summanen P, Immonen I, Kivela T, et al. Radiation related complications after ruthenium plaque radiotherapy of uveal melanoma. Br J Ophthalmol 1996; 80 (8): 732-9
29. Krepler K, Wedrich A, Schranz R. Intraocular hemorrhage associated with dental implant surgery. Am J Ophthalmol 1996; 122 (5): 745-6
30. Kokame GT. Vitreous hemorrhage after intravitreal tissue plasminogen activator (t-PA) and pneumatic displacement of submacular hemorrhage. Am J Ophthalmol 2000; 129 (4): 546-7
31. Mootha VV, Schluter ML, Das A. Intraocular hemorrhages due to warfarin fluconazole drug interaction in a patient with presumed Candida endophthalmitis. Arch Ophthalmol 2002; 120 (1): 94-5
32. Tilanus MA, Vaandrager W, Cuypers MH, et al. Relationship between anticoagulant medication and massive intraocular hemorrhage in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 2000; 238 (6): 482-5
33. Manuchehri K, Loo A, Ramchandani M, et al. Acute suprachoroidal haemorrhage in a patient treated with streptokinase for myocardial infarction. Eye 1999; 13 (5): 685-6
34. Chorich LJ, Derick RJ, Chambers RB, et al. Haemorrhagic ocular complications associated with the use of systemic thromolytic agents. Ophthalmology 1988; 105: 482-31
35. West JF, Gregor ZJ. Fibrovascular ingrowth and recurrent haemorrhage following diabetic vitrectomy. Br J Ophthalmol 2000; 84 (8): 822-5
36. Wu WC, Chang SM, Chen JY, et al. Management of postvitrectomy diabetic vitreous hemorrhage with tissue plasminogen activator (t-PA) and volume homeostatic fluid-fluid exchanger. J Ocul Pharmacol Ther 2001; 17 (4): 363-71
37. Koutsandrea C, Apostolopoulos M, Theodossiadis P. The use of tissue plasminogen activator in postvitrectomy cases. Int Ophthalmol 1993; 17 (2): 95-100
38. Zhao P, Wang W, Song H, et al. Repetitive, low-dose tissue plasminogen activator for clearance of experimental vitreous hemorrhage. Yan Ke Xue Bao 1995; 11 (1): 29-31, 40
39. Min WK, Kim YB, Ahn BH, et al. Repetitive, low-dose tissue plasminogen activator for clearance of experimental vitreous hemorrhage. Korean J Ophthalmol 1994; 8 (2): 45-8
40. Johnson RN, Olsen KR, Hernandez E. Intrevitreal tissue plasminogen activator treatment of experimental vitreous haemorrhage. Arch Ophthalmol 1989; 107 (6): 891-4
41. The Diabetes Control and Complications Trial Research Group. Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial. Ophthalmology 1995; 102: 647-61
42. Early Treatment Diabetic Retinopathy Study Research Group. Early photocoagulation for diabetic retinopathy. ETDRS Report Number 9. Ophthalmology 1991; 98: 766-85
43. The Diabetic Retinopathy Vitrectomy Study Group. Early vitrectomy for severe proliferative diabetic retinopathy in eyes with useful vision: clinical application of results of a randomized trial. Diabetic Retinopathy Vitrectomy Study Report 4. Ophthalmology 1998; 95 (10): 1321-34
44. Boehm BO, Lang GK, Jehle PM, et al. Ocreotide reduces vitreous haemorrhage and loss of visual acuity risk in patients with high-risk proliferative diabetic retinopathy. Horm Metab Res 2001; 33 (5): 300-6